EMB-Fatol® 100 mg clinical trials

ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)

This study is testing a new inhaled medicine for people with a lung infection called MAC. It wants to see if the new medicine, given with other standard treatments, makes breathing symptoms better and helps clear the infection compared to standard treatments alone.